Komodo and cancer charity map out dealing with colorectal cancer

The less people want to talk about a subject the more the industry has to push to get the word and information out. For colorectal cancer awareness month, Komodo Health, working with Fight Colorectal Cancer (Fight CRC), is the latest pharma to emphasize the importance of managing the second most deadly form of cancer, with the introduction of the Fight CRC Provider Finder.

The Provider Finder, which can be found on Fight CRC’s website, is a digital resource to help find the best HCPs in the U.S. throughout all stages of the disease.  The user can choose providers based on location, expertise, and if they are involved with clinical trials and use biomarkers.

“The healthcare systems are very complicated,” Usha Periyanayagam, MD, MPH, head of clinical product and RWE, Komodo Health said. “It's really hard to find the right doctor to reach out at the right time to get the right answers. So the question becomes how do I do that?”

You can hear more from Anjee Davis, president of Fight Colorectal Cancer, on our podcast Podnosis

 

Periyanayagam also spoke about Komodo’s work at the Call-on Congress event which took place in Washington, D.C. on March, 17. The event included virtual meetings with members of Congress urging them to focus on dealing with the disease which is on track to be the leading cause of cancer deaths for people under 50.

Fight CRC created United in Blue, “the first-ever installation on the National Mall to spotlight colorectal cancer as a national priority and raise awareness that we need to fight for more.” It featured 27,400 blue flags on the Mall representing the people under the age of 50 estimated to be diagnosed with colorectal cancer by 2030. 

The effort is supported by a strong mix of media including Fight CRC’s #StrongArmSelfie. All the work has been promoted over a variety of social media channels including Twitter, LinkedIn, Youtube, Facebook and Instagram.

According to Fight CRC, at the height of the pandemic colonoscopy screenings and biopsies fell by 90%. So this year’s colorectal cancer month has seen a lot of initiatives by a lot of different organizations to try and counteract the damage the pandemic has wrought when it comes to the disease. In May, the U.S. Preventive Services Task Force lowered the colorectal cancer screening rate from 50 to 45, making 45 million Americans eligible to be checked for the potentially life-threatening disease.